Vascular selectivity of seven prototype calcium antagonists: a study at the single cell level

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Cell Biology

Background:

• Vascular selective calcium antagonists (CAs) are crucial for hypertension management due to improved tolerance and fewer cardiac side effects.
• Understanding the differential effects of CAs on vascular and cardiac tissues is essential for optimizing therapeutic strategies.

Purpose of the Study:

• To compare the vascular selectivity of seven well-known CAs.
• To investigate the influence of stimulation frequency on CA efficacy in cardiac and vascular smooth muscle cells.

Main Methods:

• Assessed inhibition of 45Ca2+ uptake in rat aortic smooth muscle cells (A7r5 cell line) to determine vascular effects.
• Measured inhibition of contractions in single isolated rat ventricular myocytes at different stimulation frequencies (0.5 Hz and 1 Hz) to determine cardiac effects.
• Calculated vascular selectivity ratios (IC25 cardiocytes/IC25 A7r5 cells) for each CA.

Main Results:

• Isradipine exhibited the highest vascular selectivity (184), followed by felodipine (128) and nifedipine (107).
• Verapamil and diltiazem showed lower selectivity and significant frequency-dependent negative inotropic effects.
• Vascular selectivity varied based on experimental conditions and stimulation frequency, suggesting complex drug-receptor interactions.

Conclusions:

• Calcium antagonists display diverse vascular selectivities and frequency-dependent profiles.
• Vascular selectivity is not solely determined by chemical class but may involve varying drug dissociation rates from channel binding sites.
• These findings highlight the importance of considering individual CA properties for effective hypertension treatment.